I don’t have any concern about public comms polluting the trials. This is the sort of thing a placebo group is intended to control for. Any placebo effect among trial participants acts equally on the placebo group and the active group, and people don’t know which group they’re in.
Remember, the placebo group and the active group both experience the placebo effect. So the question is, is there a stronger placebo effect in the placebo group than the active group? In practical terms there’s probably a minority of participants closely following corporate comms, so while the trial design is appropriately powered to pick up a real drug effect, it’s likely severely underpowered to pick up any comms driven difference in the placebo response in the two groups. So I think the company should make as much noise as it can.
And I do think that word will start to spread like wildfire among the OA community as successful reads start to appear, and it’s the CEO’s job to fan it every way he can.
- Forums
- ASX - By Stock
- research reports and media
I don’t have any concern about public comms polluting the...
-
- There are more pages in this discussion • 1,586 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAR (ASX) to my watchlist
|
|||||
Last
23.0¢ |
Change
-0.005(2.13%) |
Mkt cap ! $80.45M |
Open | High | Low | Value | Volume |
23.5¢ | 24.0¢ | 23.0¢ | $63.43K | 270.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
10 | 213534 | 23.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
23.5¢ | 76890 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
9 | 201534 | 0.230 |
10 | 115252 | 0.225 |
11 | 96477 | 0.220 |
3 | 47958 | 0.215 |
6 | 85461 | 0.210 |
Price($) | Vol. | No. |
---|---|---|
0.235 | 76890 | 2 |
0.240 | 703 | 1 |
0.245 | 59096 | 2 |
0.250 | 63573 | 3 |
0.255 | 29564 | 3 |
Last trade - 16.10pm 05/09/2024 (20 minute delay) ? |
Featured News
PAR (ASX) Chart |